With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Norepinephrine Transporter-Targeted Pharmacotherapy of Aggressive Neuroblastoma||Children's Hospital of Philadelphia / Michael Chorny, PhD, Garrett M. Brodeur, PhD & Ivan S. Alferiev, PhD||Innovation Grants||2019||Pennsylvania|
|Novel Genomic Drivers in Pediatric Polyposis Syndromes||Children's Hospital of Philadelphia / Suzanne MacFarland, MD||Young Investigator Grants||2019||Pennsylvania|
|Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs||University of Alberta / Hasan Uludag, PhD, Joseph Brandwein, PhD & Xiaoyan Jiang, MD/PhD||Innovation Grants||2019||Alberta|
|Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells||Stanford University School of Medicine / Alice Bertaina, MD/PhD||Reach Grants||2019||California|
|Overcoming Obstacles to Drug Development in Pediatric Cancer||Stanford University School of Medicine / Crystal L. Mackall, MD||Crazy 8 Initiative||2019||California|
|Pediatric Osteosarcoma: Identifying the elusive molecular signature and its relationship to this disease||St. Jude Children's Research Hospital / Linda Hendershot, PhD||Innovation Grants||2019||Tennessee|
|Platform development for target identification in high risk pediatric leukemias||Columbia University / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD/PhD||Crazy 8 Initiative||2019||New York|
|Platform development for target identification in high risk pediatric leukemias||St. Jude Children's Research Hospital / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD/PhD||Crazy 8 Initiative||2019||Tennessee|
|Practical, Reproducible, and Statistically-Rigorous Workflows for Single-Nucleus Analysis of Childhood Cancer Data||Johns Hopkins Bloomberg School of Public Health / Stephanie C. Hicks, PhD||Crazy 8 Initiative||2019||Maryland|
|Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma||City of Hope National Medical Center / Linda Malkas, PhD||Reach Grants||2019||California|